This site is intended for Healthcare Professionals only.

At-risk groups encouraged to sign up for Covid-19 vaccine trials

Date:

Share post:

The government today (Monday, Aug 17) urged elderly people and volunteers from black, Asian and minority ethnic backgrounds to sign up to a Covid-19 vaccine trial registry to boost efforts to find a working vaccine against the disease that offers protection against higher risk groups.

No vaccine candidate has yet been proven effective against the disease, but around 20 are in clinical trials.

“Over 100,000 people have volunteered to take part in vaccine trials,” the government said in a statement, adding that more volunteers were needed to make sure candidate shots work for everyone.

Business Secretary Alok Sharma said: “Scientists and researchers are working day and night to find a vaccine that meets the UK’s rigorous regulatory and safety standards, but they need hundreds of thousands of people of all backgrounds and ages to sign-up for studies to speed up this vital research.

“I urge everyone to play our part in the fight against coronavirus and join the 100,000 people who have already registered, so we can help save and protect millions of lives.”

The government said it was particularly keen for over 65s, frontline health and care workers and people from black, Asian and minority ethnic backgrounds to sign up.

“Protecting those at risk is the only way we will end this pandemic,” said Kate Bingham, chair of the UK Vaccines Taskforce.

“That’s why we are working as quickly as possible to run clinical studies on the most promising vaccines to see whether they offer protection against Covid-19, whilst adhering to the UK’s strict safety and regulatory processes. And we need people throughout the UK to sign up to the registry to help us achieve this.”

A study last week showed that minority ethnic groups were two to three times more likely to have had Covid-19 compared to white people in England. Disproportionate numbers of people from minority groups have also died from the disease.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

40% of Brits ready to embrace pharmacy delivery service

Same-day delivery and real-time tracking could be key to winning over consumers skeptical about pharmacy delivery service A survey...

PDA opposes DiCE guidance on online prescribing for GLP-1 agonist

PDA has withheld its endorsement of the DiCE guidance due to concerns over patient safety The Pharmacist's Defence Association...

Locum Pharmacist acquires 30-hour Moorside Pharmacy

The new owner plans to run Moorside Pharmacy on a hands-on basis and introduce additional services for the...

Breakthrough: Cabotegravir shows 88% reduction in HIV-1 incidence

Recommended by NICE and approved by the MHRA, Cabotegravir 600 mg long-acting injection is the first injectable treatment...